Atlas Trials

Phase II Study of 5-FU, Oxaliplatin Plus Dasatinib in Metastatic Pancreatic Adenocarcinoma

Clinical trial NCT01652976 · COMPLETED

Trial details

NCT number
NCT01652976
Sponsor
University of Florida
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic Cancer Metastatic
Start date
2012-07-01
Primary completion
2018-02-01
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.